Avitide Garners $3,435,003 New Funding

  • Feed Type
  • Date
    6/9/2014
  • Company Name
    Avitide
  • Mailing Address
    7 Lucent Drive Lebanon, NH 03766 USA
  • Company Description
    Avitide develops customized biopharmaceutical affinity purification products. The Avitide platform reduces bioprocess development timelines, program risk, and cost of manufacture by providing turnkey, cost-effective, highly specific affinity purification solutions.
  • Website
    http://www.avitide.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,435,003
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor